Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Pharmaceuticals & Biotech » New Report Provides a Comprehensive Insight into the Indian Insulin, Oral Antidiabetics and Diabetes Diagnostics Market
“Indian Diabetes Market Report”
Driven by a rising patient pool and continuously increasing healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in India. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments – Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in India
  • Historical, current and future prevalence of type-1 and type-2 diabetes in India
  • Historical, current and future prevalence of diabetes in the urban and rural regions in India
  • Historical, current and future prevalence of diabetes among males and females in India
  • Historical, current and future prevalence of diabetes among various age groups in India
  • Historical, current and future diagnosis rates for diabetes in India
  • Historical, current and future drug treatment rates for diabetes in India


Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook


Comprehensive situation analysis of the Indian Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook


Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook 


Table of Contents:

1 Research Methodology

2 Executive Summary

3 Diabetes Disease Overview

3.1 What is Diabetes?

3.2 Diabetes Diagnosis and Treatment

3.2.1 Diagnosis

3.2.2 Treatment

3.3 Diabetes Complications

4 Factors Driving the Diabetes Market in India

4.1 Increasing Obesity Levels

4.2 Urbanization

4.3 India has the Second Largest Diabetes Patient Base in the World

4.4 India Represents One of the Fastest Growing Markets Globally

4.5 Improving Diagnosis and Treatment Rates

5 The Indian Diabetes Epidemiology

5.1 Diabetes Population and Prevalence Rates

5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)

5.3 Population and Prevalence Rates by Region (Urban and Rural)

5.4 Population and Prevalence Rates by Gender

5.5 Population and Prevalence Rates by Age Group

5.6 Diabetes Diagnosis and Drug Treatment Rates

6 Indian Diabetes Market

6.1 Historical Market Trends (2007-2014)

6.2 Market Breakup by Segment (2007-2014)

6.3 The Indian Oral Antidiabetics Market

6.3.1 Historical Market Trends (2007-2014)

6.3.2 Market Breakup by Class (2007-2014)

6.3.3 Market Shares of Key Players

6.3.4 Market Outlook (2015-2020)

6.4 The Indian Insulin Market

6.4.1 Historical Market Trends (2015-2020)

6.4.2 Market Breakup by Class

6.4.3 Market Shares of Key Players

6.4.4 Market Outlook (2015-2020)

6.5 Market Outlook (2015-2020)

7 Indian Diabetes Diagnostics Market

7.1.1 Historical Market Trends (2007-2014)

7.1.2 Market Segmentation

7.1.3 Market Shares of Key Players

7.1.4 Market Outlook (2015-2020)


List of Figures

Figure 3 1: The Impact of Diabetes on the Human Body

Figure 3 2: Diabetes Complications

Figure 4 1: India: Overweight & Obese Population (in Millions), 2007, 2014 & 2020

Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes

Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 & 2030

Figure 5 1: India: Total Number of Diabetes Patients (in Millions), 2007- 2014

Figure 5 2: India: Total Number of Diabetes Patients (in Millions), 2015 – 2020

Figure 5 3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014

Figure 5 4: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions) 2015 – 2020

Figure 5 5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014

Figure 5 6: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2015 – 2020

Figure 5 7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2007- 2014

Figure 5 8: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2015 – 2020

Figure 5 9: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2007- 2014

Figure 5 10: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2015 – 2020

Figure 5 11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2007- 2014

Figure 5 12: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2015 – 2020

Figure 6 1: India: Diabetes Market (in Million US$), 2007-2014

Figure 6 2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014

Figure 6 3: India: Oral Antidiabetics Market (in Million US$), 2007-2014

Figure 6 4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014

Figure 6 5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)

Figure 6 6: India: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020

Figure 6 7: India: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020

Figure 6 8: India: Insulin Market (in Million US$), 2005-2012

Figure 6 9: India: Insulin Market: Sales Share of Key Classes (in %), 2012

Figure 6 10: India: Insulin Market: Sales Share of Key Players (in %), 2012

Figure 6 11: India: Insulin Market Forecast (in Million US$), 2015-2020

Figure 6 12: India: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020

Figure 6 13: India: Diabetes Market Forecast (in Million US$), 2015-2020

Figure 6 14: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020

Figure 7 1: India: Glucose Monitoring Market (in Million US$), 2007-2014

Figure 7 2: India: Glucose Monitoring Market: Sales Share by Segment (in %),

Figure 7 3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)

Figure 7 4: India: Glucose Monitoring Market Forecast (in Million US$), 2015-2020


List of Tables

Table 2 1: India: Diabetes Epidemiology: Executive Summary

Table 2 2: India: Diabetes Market: Executive Summary

Table 3 1: Diagnosis of Diabetes

Table 4 1: India: Overweight & Obesity Statistics, 2006, 2010 & 2014

Table 4 2: India: Urban & Rural Population Breakup (in Millions), 1991, 2001, 2011 & 2014

Table 4 3: Global: Diabetes Population Breakup by Country (in 000’s), 2014 & 2020

Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets

Table 5 1: India: Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020

Table 5 2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020

Table 5 3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020

Table 5 4: India (Male & Female): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020

Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2007, 2014 & 2020

Table 5 6: India: Total Diagnosed & Drug Treated Diabetes Population, 2007, 2014 & 2020


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099 

IMARC Group North America:
Email:  america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:
Email:ema@imarcgroup.com
Phone: +44-702-409-7331 

To know more please visit: http://www.imarcgroup.com/india-diabetes


About IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

To know more about our company, please visit: http://www.imarcgroup.com/

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: sales@imarcgroup.com
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

Comments are closed.